1998
DOI: 10.1177/002215549804600607
|View full text |Cite
|
Sign up to set email alerts
|

Differential Localization of Cysteine Protease Inhibitors and a Target Cysteine Protease, Cathepsin B, by Immuno-Confocal Microscopy

Abstract: SUMMARYThe cystatin superfamily of cysteine protease inhibitors and target cysteine proteases such as cathepsin B have been implicated in malignant progression. The respective cellular/extracellular localization of cystatins and cysteine proteases in tumors may be critical in regulating activity of the enzymes. Confocal microscopy has enabled us to demonstrate the differential localization of cystatins and cathepsin B in an embryonic liver cell line and an invasive hepatoma cell line. In both, stefins A and B … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
24
0

Year Published

2001
2001
2010
2010

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 53 publications
(27 citation statements)
references
References 28 publications
3
24
0
Order By: Relevance
“…CysB immunostaining in brains of WT mice in this study shows cytoplasmic and lysosomal localization, supporting earlier findings that CysB is distributed diffusely throughout the cytoplasm 42 and localized mainly within lysosomal compartments. 43 We confirm and extend the reports that CysB has a role in lysosomal functioning and that loss-of-function in EPM1 and subsequent lysosomal dysfunction are the major pathogenic factors in the disease.…”
Section: In Vivosupporting
confidence: 92%
“…CysB immunostaining in brains of WT mice in this study shows cytoplasmic and lysosomal localization, supporting earlier findings that CysB is distributed diffusely throughout the cytoplasm 42 and localized mainly within lysosomal compartments. 43 We confirm and extend the reports that CysB has a role in lysosomal functioning and that loss-of-function in EPM1 and subsequent lysosomal dysfunction are the major pathogenic factors in the disease.…”
Section: In Vivosupporting
confidence: 92%
“…Quantitatively different combinations of cystatins are the major constituents of the inhibition of cathepsin B in squamous cell lung cancer and normal lung tissue (Krepela et al, 1998). Cathepsin B and its endogenous inhibitors may facilitate proteolysis by hepatoma cells and thereby contribute to the invasive phenotype of this type of cancer (Calkins et al, 1998). An inverse correlation between amounts of cathepsin B and cystatin C has been found in a study of human colorectal cancer (Hirai et al, 1999).…”
Section: Discussionmentioning
confidence: 99%
“…Cystatin B (also called stefin B) belongs to the cystatin superfamily of cysteine protease inhibitors and target cysteine proteases, such as cathepsin B. Cystatin B has been implicated in malignant progression [33] and alterations in its expression, processing, and localization have been observed at various levels in malignant human tumors [34]. Progressively higher levels of cystatin B have been associated, e.g., with short survival in patients Table 1 for their classification).…”
Section: Downregulated Proteinsmentioning
confidence: 99%